As of 2026-06-16, the Relative Valuation of KemPharm Inc (KMPH) is (20.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -456.9%.
The range of the Relative Valuation is (15.92) - (20.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 23.0x | 19.7x |
| Forward P/E multiples | 10.3x - 16.8x | 14.8x |
| Fair Price | (15.92) - (20.27) | (20.74) |
| Upside | -374.0% - -449.0% | -456.9% |
| Date | P/E |